Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 14/20 | 0.45 |
| ▸ | RARB | P10826 | 9/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | RARG | P13631 | 9/20 | 0.38 |
| ▸ | RARA | P10276 | 7/20 | 0.38 |
| ▸ | RXRB | P28702 | 9/20 | 0.37 |
| ▸ | RXRG | P48443 | 8/20 | 0.37 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.35 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CRABP2 | P29373 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15347776 | 0.91 | RXRA (0.50) | RXRARARBTP53CYP1A2RARG | |
| SCHEMBL196263 | 0.79 | RXRA (0.35) | RXRARARBTP53CYP1A2CYP3A4 | |
| SCHEMBL19101607 | 0.79 | CYP1A2 (0.42) | RXRARARBTP53CYP1A2RARG | |
| SCHEMBL29569404 | 0.79 | RXRA (0.35) | RXRARARBTP53CYP1A2CYP3A4 | |
| SCHEMBL6224470 | 0.77 | RXRA (0.46) | RXRARARBTP53CYP1A2RARG | |
| SCHEMBL21440625 | 0.77 | RXRA (0.38) | RXRARARBTP53RARGRARA | |
| SCHEMBL23633278 | 0.77 | ALDH1A1 (0.54) | RXRARARBTP53CYP1A2RARG | |
| SCHEMBL9867919 | 0.76 | RXRA (0.44) | RXRARARBTP53CYP1A2RARG | |
| SCHEMBL7806009 | 0.76 | RXRA (0.44) | RXRARARBTP53CYP1A2RARG | |
| SCHEMBL5846259 | 0.76 | RXRA (0.46) | RXRARARBTP53CYP1A2RARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230178848-A1 | ELECTRODE SEPARATORS | UNIV KING ABDULLAH SCI & TECH (SA) | 2023-06-08 | — | — | US | disclosed |
| US-20230178848-A1 | ELECTRODE SEPARATORS | UNIV KING ABDULLAH SCI & TECH (SA) | 2023-06-08 | — | — | US | disclosed |
| EP-3837038-B1 | DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF | UNIV CALIFORNIA (US) | 2023-02-15 | — | — | EP | disclosed |
| US-20210309802-A1 | DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF | UNITED STATES DEPARTMENT OF ENERGY | 2021-10-07 | — | — | US | disclosed |
| WO-2020037246-A1 | DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2020-02-20 | — | — | WO | disclosed |
| US-20160367948-A1 | CROSSLINKED POLYMER, METHOD FOR PRODUCING THE SAME, MOLECULAR SIEVE COMPOSITION AND MATERIAL SEPARATION MEMBRANES | KYOTO UNIVERSITY (JP) | 2016-12-22 | — | — | US | disclosed |
| US-20160367948-A1 | CROSSLINKED POLYMER, METHOD FOR PRODUCING THE SAME, MOLECULAR SIEVE COMPOSITION AND MATERIAL SEPARATION MEMBRANES | KYOTO UNIVERSITY (JP) | 2016-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210309802-A1 | DIVERSITY-ORIENTED POLYMERS OF INTRINSIC MICROPOROSITY AND USES THEREOF | PARN, PARG, PAM | RXRA 1355/4885RARB 747/4885TP53 4125/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.